Influence of the cytapheresis on cytomegalovirus reactivation complicated with ulcerative colitis: a prospective study

Influence of the cytapheresis on cytomegalovirus reactivation complicated with ulcerative colitis: a prospective study - Cytapheresis for CMV reactivation in UC

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033740

Enrollment

Registered

2018-09-18

Start date

2018-08-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients fulfilling all of the following criteria were subjected to the survey. 1. Diagnosed UC patients who underwent CAP according to well-known criteria. 2. Patients who understood the purpose of experiment and signed a consent form. 3. Patients with CMV reactivation.

Exclusion criteria

Exclusion criteria: 1. The patient allergic to anticoagulant drugs. 2. When the principal investigator considered not suitable.

Design outcomes

Primary

Measure	Time frame
The intent of the study is to assess changes of the number of anti-cytomegalovirus pp65 positive cells in the patients with ulcerative colitis before and after the column and single CAP.	—

Secondary

Measure	Time frame
1. To assess changes of the number of anti-cytomegalovirus pp65 positive cells in the patients with ulcerative colitis before and after the column and single CAP. 2. Serologic marker 3. Endoscopic activity 4. Clinical severity index 5. Histological findings: histological activity; Immunohistostaining; The presence of nuclear inclusions	—

Countries

Japan

Contacts

Public ContactShintaro Sagami

Kitasato University Kitasato Institute Hospital Center for Advanced IBD Research and Treatment

jaken1013@live.jp0334446161

Outcome results